Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Hindrik Mulder

Hindrik Mulder

Principal investigator

Hindrik Mulder

Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.


  • Ruben Smith
  • Karl Bacos
  • Valentina Fedele
  • Denis Soulet
  • Helena Jones
  • Stefanie Obermüller
  • Anders Lindqvist
  • Maria Björkqvist
  • Pontus Klein
  • Patrik Önnerfjord
  • Patrik Brundin
  • Hindrik Mulder
  • Jia-Yi Li

Summary, in English

Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG-expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular beta-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing beta-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using immunoprecipitation of mutant and wild-type huntingtin in combination with mass spectrometry, we reveal an enhanced and aberrant interaction between mutant huntingtin and beta-tubulin, implying the underlying mechanism of impaired intracellular transport. Thus, our findings have revealed a novel pathogenetic process by which mutant huntingtin may disrupt hormone exocytosis from beta-cells and possibly impair vesicular transport in any cell that expresses the pathogenic protein.


  • Department of Experimental Medical Science
  • Insulin Signal Transduction
  • Islet cell physiology
  • Translational Neuroendocrinology
  • Rheumatology

Publishing year







Human Molecular Genetics





Document type

Journal article


Oxford University Press


  • Medical Genetics



Research group

  • Insulin Signal Transduction
  • Islet cell physiology
  • Translational Neuroendocrinology


  • ISSN: 0964-6906